Access cutting-edge liver cancer treatment through this clinical trial at a research site in Falls Church. Study-provided care at no cost to qualified participants.
Access liver cancer specialists in Falls Church at no cost
This study follows strict safety protocols and ethical guidelines
All study-related liver cancer treatment provided free
This is a single-site prospective study to describe efficacy endpoints of single agent memantine in patients with unresectable, locally advanced, or metastatic HCC otherwise not deemed candidates for intensive systemic therapy. In addition to the primary endpoint and multiple secondary efficacy endpoints, we will describe changes in quality of life on treatment over time.
Sponsor: Inova Health Care Services
Check if you qualify for this liver cancer clinical trial in Falls Church, VA
If you're searching for liver cancer treatment options in Falls Church, VA, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Falls Church research site is actively enrolling participants for this clinical trial. You'll receive care from experienced liver cancer specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.